ERYTHROMYCIN

Pre-Launch

erythromycin

NDAFOR RX COMPOUNDINGPOWDER

Lifecycle

Pre-Launch

Clinical Trials

Mechanism of Action

CLINICAL PHARMACOLOGY Orally administered erythromycin base and its salts are readily absorbed in the microbiologically active form. Interindividual variations in the absorption of erythromycin are, however, observed, and some patients do not achieve optimal serum levels. Erythromycin is largely…

Indications (8)

the following infections caused by Chlamydia trachomatis : conjunctivitis of the newborn pneumonia of infancy urogenital infections during pregnancy uncomplicated urethral endocervical rectal infections in adults due to Chlamydia trachomatis nongonococcal urethritis caused by Ureaplasma urealyticum penicillin-allergic patients

Clinical Trials (5)

NCT06948747Phase 1Completed

A Study to Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Started May 2025

49 enrolled

Healthy Participants

NCT06917872Phase 1Completed

A Study in Healthy People to Test Whether Erythromycin Influences the Amount of BI 1291583 in the Blood

Started Apr 2025

20 enrolled

Healthy

NCT05797753Phase 1Completed

A Study to Assess the Effect of Erythromycin on the Test Medicine (SAR443820) When Given Orally as Tablets to Healthy Adult Male and Female Participants (Part A); and the Effect of Itraconazole on the Test Medicine (SAR443820) When Given Orally as Capsules to Healthy Adult Male Participants (Part B)

Started Feb 2022

16 enrolled

Amyotrophic Lateral SclerosisHealthy Volunteer

NCT03480243Phase 1Completed

Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil

Started Mar 2018

28 enrolled

Pharmacokinetics

NCT01478256Phase 4Completed

Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis

Started Aug 2011

30 enrolled